Unlock stock picks and a broker-level newsfeed that powers Wall Street.

NYSE American - Nasdaq Real Time Price USD

InfuSystem Holdings, Inc. (INFU)

4.8500
+0.1000
+(2.11%)
At close: May 2 at 4:00:00 PM EDT
4.8500
+0.03
+(0.62%)
After hours: May 2 at 4:05:12 PM EDT
Loading Chart for INFU
  • Previous Close 4.7500
  • Open 4.7800
  • Bid 4.7400 x 1800
  • Ask 5.0000 x 900
  • Day's Range 4.7600 - 4.8950
  • 52 Week Range 4.6100 - 9.9700
  • Volume 67,373
  • Avg. Volume 134,166
  • Market Cap (intraday) 101.93M
  • Beta (5Y Monthly) 1.90
  • PE Ratio (TTM) 44.09
  • EPS (TTM) 0.1100
  • Earnings Date May 8, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 14.12

InfuSystem Holdings, Inc., through its subsidiaries, provides infusion pumps and related products and services in the United States and Canada. It operates in two segments, Patient Services and Device Solutions. The company supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states. It also sells and rents new and pre-owned pole-mounted and ambulatory infusion pumps, and other durable medical equipment; sells treatment-related consumables; and provides biomedical recertification, maintenance, and repair services for oncology practices, as well as other healthcare site settings comprising hospitals, home care and home infusion providers, skilled nursing and acute care facilities, pain centers, and others. In addition, the company offers local and field-based customer support, as well as operates pump service and repair centers. The company was incorporated in 2005 and is headquartered in Rochester Hills, Michigan.

www.infusystem.com

502

Full Time Employees

December 31

Fiscal Year Ends

Recent News: INFU

View More

Performance Overview: INFU

Trailing total returns as of 5/2/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

INFU
42.60%
S&P 500 (^GSPC)
3.31%

1-Year Return

INFU
34.64%
S&P 500 (^GSPC)
12.29%

3-Year Return

INFU
40.85%
S&P 500 (^GSPC)
36.85%

5-Year Return

INFU
59.85%
S&P 500 (^GSPC)
100.89%

Compare To: INFU

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: INFU

View More

Valuation Measures

Annual
As of 5/2/2025
  • Market Cap

    101.93M

  • Enterprise Value

    129.83M

  • Trailing P/E

    44.09

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.78

  • Price/Book (mrq)

    1.77

  • Enterprise Value/Revenue

    0.96

  • Enterprise Value/EBITDA

    6.71

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    1.74%

  • Return on Assets (ttm)

    4.53%

  • Return on Equity (ttm)

    4.27%

  • Revenue (ttm)

    134.86M

  • Net Income Avi to Common (ttm)

    2.35M

  • Diluted EPS (ttm)

    0.1100

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    527k

  • Total Debt/Equity (mrq)

    51.98%

  • Levered Free Cash Flow (ttm)

    2.09M

Research Analysis: INFU

View More

Company Insights: INFU

Research Reports: INFU

View More

People Also Watch